Metraipolis › archive › dc_d3f4d0b217c8

Antibody‒drug conjugates with DHODH inhibitor as novel payload class for cancer and SARS-CoV-2 infection therapies — Europe PMC PMID:41685151

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41685151
DOI
10.1016/j.apsb.2025.11.008
License (as archived)
solo-consultazione
Archived
2026-11-08T15:23:15.023Z
SHA-256 of the archived text
deafdbeacc6695a3dcf71afabd1a5f7d84d91b16522d403a7f7d81e69fd819f8
Stable URL of this page
https://metraipolis.com/documento/dc_d3f4d0b217c8

How to cite

Antibody‒drug conjugates with DHODH inhibitor as novel payload class for cancer and SARS-CoV-2 infection therapies — Europe PMC PMID:41685151 — Europe PMC (en), https://europepmc.org/article/MED/41685151 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d3f4d0b217c8 (Metraipolis archive dc_d3f4d0b217c8, sha256 deafdbeacc6695a3dcf71afabd1a5f7d84d91b16522d403a7f7d81e69fd819f8)
BibTeX
@misc{dcd3f4d0b217c8,
  title = {Antibody‒drug conjugates with DHODH inhibitor as novel payload class for cancer and SARS-CoV-2 infection therapies — Europe PMC PMID:41685151},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41685151},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d3f4d0b217c8; sha256 deafdbeacc6695a3dcf71afabd1a5f7d84d91b16522d403a7f7d81e69fd819f8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41685151. Agents can read the archived copy with the MCP tool read_document.